MWPC 005
Alternative Names: MW-005; MWPC-005Latest Information Update: 19 Jul 2023
At a glance
- Originator MediWound
- Class Antineoplastics; Enzymes; Skin disorder therapies
- Mechanism of Action Peptide hydrolase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Skin cancer
- Phase I/II Basal cell cancer